SEC Form 4

FORM 4		UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940	OMB APPROVAL OMB Number: 3235-0287 Estimated average burden hours per response: 0.5
	Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person* Trpik Joseph R JR (Last) (First) (Middle) 10 S. DEARBORN STREET 54TH FLOOR (Street) CHICAGO IL 60603 (City) (State) (Zip)	2. Issuer Name and Ticker or Trading Symbol EXELON CORP [ EXC ]	5. Relationship of Reporting Person(s) to Issuer (Check all applicable) Director 10% Owner X Officer (give title below) Other (specify below) SVP & Corp. Controller
	3. Date of Earliest Transaction (Month/Day/Year) 10/28/2022
	4. If Amendment, Date of Original Filed (Month/Day/Year)	6. Individual or Joint/Group Filing (Check Applicable Line) X Form filed by One Reporting Person Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Unit Award (10/28/2022)	(1)	10/28/2022(1)		A		25,000(1)		(1)	(1)	Common stock	25,000	(1)	25,000	D
Restricted Stock Unit Award (05/02/2022)	(2)							(2)	(2)	Common stock	919		919(2)	D
Restricted Stock Unit Award (01/28/2022)	(3)							(3)	(3)	Common stock	2,913		2,913(3)	D
Restricted Stock Unit Award (01/25/2021)	(4)							(4)	(4)	Common stock	2,627		2,627(4)	D
Restricted Stock Unit Award (01/27/2020)	(5)							(5)	(5)	Common stock	1,252		1,252(5)	D
Earned Performance RSU	(6)							(6)	(6)	Common stock	7,298		7,298(6)	D
Deferred Phantom Shares	(7)							(7)	(7)	Common stock	516		516(7)	D

Explanation of Responses:

1. RSU award granted pursuant to the Exelon Long Term Incentive Plan; Award vests in 1/3 increments on the first, second and third anniversary of the grant date referenced in Column 1 subject to the reporting person's continued employment with the company. Each RSU represents the right to receive one share of Exelon common stock upon vesting. Unvested award balance accrues additional units through automatic dividend reinvestment, which vest on the same schedule as the underlying award.

2. Additional RSU award granted in May 2022 pursuant to the Exelon Long Term Incentive Plan; this award vests in 1/3 increments on the date of the Compensation Committee's January or February meeting in the first, second and third years after the award was granted. Balance includes 13 shares acquired through automatic dividend reinvestment.

3. Annual RSU award granted in January 2022 pursuant to the Exelon Long Term Incentive Plan; each award vests in 1/3 increments on the date of the Compensation Committee's January or February meeting in the first, second and third years after the award was granted. Balance includes 42 shares acquired through automatic dividend reinvestment.

4. Remaining 2/3 increment of annual RSU award granted in January 2021 pursuant to the Exelon Long Term Incentive Plan; each award vests in 1/3 increments on the date of the Compensation Committee's January or February meeting in the first, second and third years after the award was granted. Balance includes 38 shares acquired through automatic dividend reinvestment.

5. Remaining 1/3 increment of annual restricted stock unit (RSU) award granted in January 2020 pursuant to the Exelon Long Term Incentive Plan; each award vests in 1/3 increments on the date of the Compensation Committee's January or February meeting in the first, second and third years after the award was granted. Balance includes 18 shares acquired through automatic dividend reinvestment.

6. RSU award granted pursuant to the Exelon Long Term Incentive Plan; Award cliff vests at the January 2023 meeting of the Compensation Committee with each RSU representing the right to receive one share of Exelon common stock upon vesting.

7. Phantom share equivalents representing units held in the Exelon stock fund in a multi-fund, non-qualified deferred compensation plan. The Exelon stock fund is a unitized fund that consists of Exelon common stock and short term investments. Units of the fund will be settled upon the reporting person's separation from the company for any reason. Units will be settled in cash. Units are acquired through regular periodic contributions, company matching contributions and the reinvestment of dividend equivalents. The balance of phantom share equivalents may fluctuate due to periodic changes in the fund composition. Balance includes- 7 share equivalents earned through automatic dividend reinvestment.

	Elizabeth M. Hensen, Attorney-in-Fact for Jospeh R Trpik, Jr.	11/01/2022
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.